U.S. Blood Collection Market Size & Outlook, 2022-2030
U.S. blood collection market, 2018-2030 (US$M)
Related Markets
U.S. blood collection market highlights
- The U.S. blood collection market generated a revenue of USD 3,707.4 million in 2022 and is expected to reach USD 6,158.5 million by 2030.
- The U.S. market is expected to grow at a CAGR of 6.5% from 2023 to 2030.
- In terms of segment, venous was the largest revenue generating collection site in 2022.
- Capillary is the most lucrative collection site segment registering the fastest growth during the forecast period.
Blood collection market data book summary
| Market revenue in 2022 | USD 3,707.4 million |
| Market revenue in 2030 | USD 6,158.5 million |
| Growth rate | 6.5% (CAGR from 2022 to 2030) |
| Largest segment | Venous |
| Fastest growing segment | Capillary |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Venous, Capillary |
| Key market players worldwide | Abbott Laboratories, Nipro Corp, BD, Terumo Corp, Medtronic PLC, Qiagen NV, Haemonetics Corp, FL Medical, Greiner Bio-One |
Other key industry trends
- In terms of revenue, U.S. accounted for 34.8% of the global blood collection market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. blood collection market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 1,164.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Blood Collection Market Scope
Blood Collection Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. blood collection market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to blood collection market will help companies and investors design strategic landscapes.
Venous was the largest segment with a revenue share of 82.4% in 2022. Horizon Databook has segmented the U.S. blood collection market based on venous, capillary covering the revenue growth of each sub-segment from 2018 to 2030.
U.S. witnessed exponential market growth due to the presence of major market players, well-developed healthcare infrastructure and increase in the R&D in the country have fueled the market growth. For instance, in August 2019, Q-Sera Pty Ltd. received the Notice of Allowance from the United States Patent & Trademark Office for the patent of Q-Sera’s technology for clotting of blood that will be used extensively in blood collection tubes.
Moreover, the adoption of innovative, advanced technology and also a large focus on clinical research in this region drives the sector growth. An increase in the number of individuals suffering from sickle cell anemia has also led to a significant requirement for blood transfusions globally.
As per, the Centers for Disease Control and Prevention, over 100, 000 individuals in the U.S. were estimated to be affected with sickle cell disease. Thus, the requirement for blood and its components is increasing at a large scale worldwide, which is anticipated to boost the market.
Reasons to subscribe to U.S. blood collection market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. blood collection market databook
-
Our clientele includes a mix of blood collection market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. blood collection market, including forecasts for subscribers. This country databook contains high-level insights into U.S. blood collection market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. blood collection market size, by collection site, 2018-2030 (US$M)
U.S. Blood Collection Market Share, 2022 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
